Dr. Aneal Khan is a Pediatrician and Medical Geneticist with more than 20 years of experience in diagnosing and treating rare genetic diseases. He did is undergraduate and graduate training at the University of Toronto, his M.D. at Queen's University in Ontario, Pediatric Residency at Rush Medical College in Chicago and at the Hospital for Sick Children in Toronto, a fellowship in Clinical Genetics at the Hospital for Sick Children in Toronto. He has worked at the Hospital for Sick Children and University Health Network initially, McMaster Children's Hospital, and Alberta Children's Hospital in Calgary nd left in 2021 as Professor of Pediatrics and Medical Genetics. He founded M.A.G.I.C. Clinic which opened it's doors to patients in April 2021 with a goal to improve access to finding a diagnosis and improve the number of treatments available for people with rare metabolic and genetic diseases.

Dr. Khan has been involved in a number of clinical trials including the first gene therapy in the world for Fabry disease and for Gaucher disease, Liver Cell Transplant for Urea Cycle Diseases, the first community-based gene therapy in Canada. He is also co-founder of a molecular genetics laboratory Discovery DNA, in Calgary and President of the Rare Disease Network of Alberta.

Dr. Khan works on a number of national and international rare disease boards, is a member of the International Advisory Group (IAG) for the National Strategy for Drugs for Rare Diseases through the Government of Canada, and is an I am Number 12 Changemaker.